Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma
Clinical trial NCT02958969 · COMPLETED
Trial details
- NCT number
- NCT02958969
- Sponsor
- Gregory Piazza
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-28
- Primary completion
- 2019-06-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.